|
Re: Response
|
3
|
Resverlogix Corp.
|
Jan 23, 2024 08:04PM
|
|
Re: Report Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Apr 16, 2024 07:45PM
|
|
Re: Report Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Apr 17, 2024 04:33PM
|
|
Re: Report Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Apr 17, 2024 05:45PM
|
|
Re: Report Of Exempt Distribution.
|
1
|
Zenith Epigenetics
|
Apr 17, 2024 07:27PM
|
|
Re: Report Of Exempt Distribution.
|
3
|
Zenith Epigenetics
|
Apr 18, 2024 09:20AM
|
|
Re: Report of exempt distribution
|
5
|
Resverlogix Corp.
|
Jul 01, 2020 03:21PM
|
|
Re: Report of exempt distribution
|
3
|
Resverlogix Corp.
|
Nov 10, 2020 04:55PM
|
|
Re: reply from Sarah
|
1
|
Zenith Epigenetics
|
Nov 27, 2021 07:07PM
|
|
Re: Reminds me of.......
|
3
|
Resverlogix Corp.
|
Jun 25, 2019 02:18PM
|
|
Re: Reminds me of.......
|
4
|
Resverlogix Corp.
|
Jun 25, 2019 02:29PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 07:32PM
|
|
Re: Recent Funding - Zenith CC
|
1
|
Zenith Epigenetics
|
Oct 24, 2022 12:05PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 09:33AM
|
|
Re: realisticly how long do they even have to try & close this "purposed offering" 4-6 weeks max?
|
1
|
Resverlogix Corp.
|
May 15, 2019 10:08AM
|
|
Re: Re San fran
|
7
|
Resverlogix Corp.
|
Oct 19, 2020 04:51PM
|
|
Re: Re San fran
|
11
|
Resverlogix Corp.
|
Oct 20, 2020 09:34AM
|
|
Re: Ray Kroc
|
1
|
Resverlogix Corp.
|
Aug 22, 2020 09:18PM
|
|
Re: Random thoughts in the vacuum of information
|
2
|
Resverlogix Corp.
|
Jun 27, 2024 03:05PM
|
|
Re: Random thoughts in the vacuum of information
|
1
|
Resverlogix Corp.
|
Jul 03, 2024 08:41PM
|
